Principal Financial Group Inc. trimmed its position in Trupanion, Inc. (NASDAQ:TRUP – Free Report) by 6.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 231,006 shares of the financial services provider’s stock after selling 15,698 shares during the period. Principal Financial Group Inc.’s holdings in Trupanion were worth $9,998,000 at the end of the most recent quarter.
A number of other institutional investors have also added to or reduced their stakes in TRUP. AlphaQuest LLC grew its stake in Trupanion by 16.5% in the third quarter. AlphaQuest LLC now owns 3,444 shares of the financial services provider’s stock valued at $149,000 after acquiring an additional 487 shares during the period. Federated Hermes Inc. bought a new position in shares of Trupanion in the 3rd quarter worth $33,000. Pilgrim Partners Asia Pte Ltd acquired a new stake in Trupanion in the 3rd quarter valued at $39,000. Y Intercept Hong Kong Ltd bought a new stake in Trupanion during the 3rd quarter valued at $1,897,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH increased its stake in Trupanion by 12.9% during the 3rd quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 48,987 shares of the financial services provider’s stock valued at $2,120,000 after purchasing an additional 5,580 shares in the last quarter.
Trupanion Stock Performance
Shares of Trupanion stock opened at $32.14 on Friday. The business’s fifty day simple moving average is $35.04 and its 200 day simple moving average is $40.25. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.31. Trupanion, Inc. has a 12 month low of $30.54 and a 12 month high of $57.88. The firm has a market capitalization of $1.39 billion, a P/E ratio of 89.28 and a beta of 1.58.
Key Headlines Impacting Trupanion
Here are the key news stories impacting Trupanion this week:
- Positive Sentiment: Revenue growth and slight beat — Q4 revenue rose ~11.7% year-over-year to $376.85M, marginally topping consensus and signaling continued policy/premium growth. Trupanion Reports Q4 — MarketBeat
- Positive Sentiment: Management emphasized strong discretionary profit track record — CEO noted >$500M in discretionary profit since 2021 with a ~22% CAGR, which supports long‑term margin improvement narratives. Trupanion Reports Q4 & Full Year 2025 Results — GlobeNewswire
- Neutral Sentiment: Revenue guidance roughly in line with consensus — Q1 revenue guidance of $376.0M–$382.0M and FY2026 revenue guidance near $1.6B track closely with analyst expectations, reducing surprise risk on top-line guidance. Trupanion Reports Q4 & Full Year 2025 Results — GlobeNewswire
- Neutral Sentiment: Operational disclosures and investor materials available — company released a slide deck and hosted a conference call (useful for digging into membership, retention, and margin cadence). Earnings Materials & Call — MarketBeat
- Negative Sentiment: EPS missed expectations — reported $0.13 vs. consensus $0.14 (miss of $0.01), which can pressure near-term sentiment given the stock’s valuation. Trupanion Q4 Earnings Miss — Zacks
- Negative Sentiment: No explicit EPS guidance provided — the company’s guidance items omitted an EPS range, leaving earnings trajectory less certain for the year and increasing forecast risk for analysts and investors. Q4 Metrics & Guidance Analysis — Zacks
- Neutral Sentiment: Corporate recognition (Stevie awards) for customer service and retention — supportive for brand/retention but unlikely to move the stock materially in the short term. Trupanion Earns Stevie Awards — GlobeNewswire
Insider Activity at Trupanion
In related news, CFO Fawwad Qureshi sold 6,202 shares of the firm’s stock in a transaction dated Wednesday, November 26th. The shares were sold at an average price of $35.45, for a total transaction of $219,860.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO John R. Gallagher sold 6,383 shares of Trupanion stock in a transaction dated Friday, November 28th. The stock was sold at an average price of $34.82, for a total transaction of $222,256.06. Following the completion of the sale, the chief operating officer directly owned 32,721 shares in the company, valued at approximately $1,139,345.22. This represents a 16.32% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 32,853 shares of company stock worth $1,181,863. 5.42% of the stock is owned by company insiders.
Analyst Ratings Changes
A number of research analysts have weighed in on the stock. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Trupanion in a research note on Monday, December 29th. Stifel Nicolaus dropped their price target on shares of Trupanion from $42.00 to $38.00 and set a “hold” rating on the stock in a research report on Thursday, January 29th. Cantor Fitzgerald decreased their price objective on Trupanion from $50.00 to $42.00 and set a “neutral” rating for the company in a report on Wednesday, January 14th. Piper Sandler lowered their price objective on Trupanion from $67.00 to $60.00 and set an “overweight” rating for the company in a research note on Friday, December 19th. Finally, Wall Street Zen lowered Trupanion from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $50.00.
Read Our Latest Stock Analysis on Trupanion
Trupanion Profile
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
See Also
- Five stocks we like better than Trupanion
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- New gold price target
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP – Free Report).
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
